Inovio Awarded up to $56 Million from CEPI to Advance DNA Vaccines Against Lassa Fever and MERS Read more
Novartis drug Afinitor DISPERZ receives FDA approval to treat TSC-associated partial-onset seizures Read more
Accelovance and Linical merge organizations to form a best-in-class CRO with increased global reach Read more
Proteostasis’ triple combination program secures FDA fast track designation for cystic fibrosis Read more